SEC Form 4 · accession 0001209191-15-030721
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tina Blasi
Officer — CEO, National Imaging Assoc.
Period of report
Mar 30, 2015
Accepted (ET)
Apr 1, 2015 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Mar 30, 2015 | X | 10,527 | $47.46 | A | 21,617 | D | |
| Ordinary Common Stock, $0.01 par valueF2 | Mar 30, 2015 | S | 10,527 | $70.018 | D | 11,090 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4,F3 | $47.46 | Mar 30, 2015 | X | 10,527 | D | — | Mar 5, 2022 | Common Stock | 10,527 | 12,600 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2The number of securities reported represents an aggregate number of shares sold in multiple open market transactions at prices ranging from $70 to $70.19, inclusive. The price reported represents the weighted average price. The Reporting Person undertakes to provide staff of the SEC, the issuer, or a stockholder of the issuer, upon request, the number of shares sold by the Reporting Person at each separate price within the range.
- F3All of the stock options in this tranche have vested in full.
- F4Not applicable.